Skip to main content

Aloxi Side Effects

Generic name: palonosetron

Medically reviewed by Drugs.com. Last updated on Dec 28, 2022.

Note: This document contains side effect information about palonosetron. Some dosage forms listed on this page may not apply to the brand name Aloxi.

Applies to palonosetron: intravenous solution.

Serious side effects of Aloxi

Along with its needed effects, palonosetron (the active ingredient contained in Aloxi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking palonosetron:

Less common

Rare

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking palonosetron:

Symptoms of overdose

Other side effects of Aloxi

Some side effects of palonosetron may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to palonosetron: intravenous solution, oral capsule.

General

The most commonly reported side effects included headache, constipation, diarrhea, and dizziness.[Ref]

Cardiovascular

Common (1% to 10%): Bradycardia/sinus bradycardia, electrocardiogram QTc prolongation, hypotension, nonsustained tachycardia/tachycardia

Uncommon (0.1% to 1%): Atrioventricular (AV) block first degree, AV block second degree, conduction disorder, extrasystoles, hypertension, myocardial ischemia, sinus arrhythmia, sinus tachycardia, supraventricular extrasystoles, vein discoloration, vein distended

Frequency not reported: Arrhythmia, blood pressure decreased, ECG T wave amplitude decreased, generalized edema, hot flash, ventricular extrasystoles

Postmarketing reports: Shock[Ref]

Gastrointestinal

Common (1% to 10%): Constipation, diarrhea, flatulence

Uncommon (0.1% to 1%): Abdominal pain, abdominal pain upper, dry mouth, dyspepsia, nausea

Frequency not reported: Intestinal hypomobility, salivary hypersecretion[Ref]

Other

Common (1% to 10%): Asthenia, weakness

Uncommon (0.1% to 1%): Fatigue, feeling hot, motion sickness, pain, pyrexia, tinnitus

Frequency not reported: Chills, fever[Ref]

Nervous system

Common (1% to 10%): Dizziness, headache

Uncommon (0.1% to 1%): Dyskinesia, hypersomnia, paresthesia, peripheral sensory neuropathy, somnolence[Ref]

Hepatic

Common (1% to 10%): Increased ALT, increased AST

Uncommon (0.1% to 1%): Blood bilirubin increased, elevated transaminases, hyperbilirubinemia

Frequency not reported: Hepatic enzymes increased, transient, asymptomatic increases in AST and/or ALT and bilirubin[Ref]

Metabolic

Common (1% to 10%): Hyperkalemia

Uncommon (0.1% to 1%): Anorexia, appetite decreased, hyperglycemia, hypocalcemia, hypokalemia, metabolic disorders

Frequency not reported: Electrolyte fluctuations, metabolic acidosis[Ref]

Dermatologic

Common (1% to 10%): Pruritus

Uncommon (0.1% to 1%): Allergic dermatitis, pruritic rash, skin disorder, urticaria[Ref]

Psychiatric

Common (1% to 10%): Anxiety

Uncommon (0.1% to 1%): Euphoric mood, insomnia[Ref]

Genitourinary

Common (1% to 10%): Urinary retention

Uncommon (0.1% to 1%): Glycosuria[Ref]

Respiratory

Uncommon (0.1% to 1%): Cough, dyspnea, epistaxis, hiccups

Frequency not reported: Hypoventilation, laryngospasm[Ref]

Ocular

Uncommon (0.1% to 1%): Amblyopia, eye irritation, eye swelling[Ref]

Local

Uncommon (0.1% to 1%): Infusion site pain, infusion site reaction

Very rare (less than 0.01%): Injection site reaction

Frequency not reported: Injection site burning, injection site discomfort, injection site induration, injection site pain[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Arthralgia, myalgia[Ref]

Hypersensitivity

Very rare (less than 0.01%): Hypersensitivity reactions

Frequency not reported: Anaphylactic shock, anaphylaxis[Ref]

Hematologic

Frequency not reported: Platelet count decreased[Ref]

Immunologic

Uncommon (0.1% to 1%): Influenza-like illness

Frequency not reported: Flu-like syndrome[Ref]

References

1. Product Information. Aloxi (palonosetron). MGI Pharma Inc. 2003.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.